Dou R, Chu Y, Han Q, Zhang W, Bi X
BMC Ophthalmol. 2024; 24(1):177.
PMID: 38632537
PMC: 11025203.
DOI: 10.1186/s12886-024-03426-5.
Tzoumas N, Riding G, Williams M, Steel D
Cochrane Database Syst Rev. 2023; 6:CD009300.
PMID: 37314061
PMC: 10266126.
DOI: 10.1002/14651858.CD009300.pub3.
Zhang Y, Huang J, Liang Y, Huang J, Fu Y, Chen N
Autophagy. 2023; 19(10):2668-2681.
PMID: 37266932
PMC: 10472852.
DOI: 10.1080/15548627.2023.2220540.
Hammadi S, Tzoumas N, Ferrara M, Meschede I, Lo K, Harris C
J Clin Med. 2023; 12(8).
PMID: 37109207
PMC: 10145879.
DOI: 10.3390/jcm12082870.
Harraka P, Wightman T, Akom S, Sandhu K, Colville D, Catran A
Sci Rep. 2022; 12(1):18301.
PMID: 36316518
PMC: 9622730.
DOI: 10.1038/s41598-022-21386-y.
Structural Features of Patients with Drusen-like Deposits and Systemic Lupus Erythematosus.
Kukan M, Driban M, Vupparaboina K, Schwarz S, Kitay A, Rasheed M
J Clin Med. 2022; 11(20).
PMID: 36294333
PMC: 9605325.
DOI: 10.3390/jcm11206012.
Characterization of Calcium Phosphate Spherical Particles in the Subretinal Pigment Epithelium-Basal Lamina Space in Aged Human Eyes.
Pilgrim M, Marouf S, Fearn S, Csincsik L, Kortvely E, Knowles J
Ophthalmol Sci. 2022; 1(3):100053.
PMID: 36247811
PMC: 9559963.
DOI: 10.1016/j.xops.2021.100053.
Retinal drusen in glomerulonephritis with or without immune deposits suggest systemic complement activation in disease pathogenesis.
Harraka P, Mack H, Colville D, Barit D, Langsford D, Pianta T
Sci Rep. 2022; 12(1):8234.
PMID: 35581312
PMC: 9114393.
DOI: 10.1038/s41598-022-12111-w.
Retinal Drusen Are More Common and Larger in Systemic Lupus Erythematosus With Renal Impairment.
Ham Y, Nicklason E, Wightman T, Akom S, Sandhu K, Harraka P
Kidney Int Rep. 2022; 7(4):848-856.
PMID: 35497809
PMC: 9039474.
DOI: 10.1016/j.ekir.2022.01.1063.
Drusen-like deposits in systemic disorders: A point of convergence for nephrologists and ophthalmologists.
Sen S
J Postgrad Med. 2021; 67(1):6.
PMID: 33565471
PMC: 8098872.
DOI: 10.4103/jpgm.JPGM_1099_20.
Choroidal Neovascularization in Primary Membranous Nephropathy.
Gambato T, Francescutti L, Lanzetta P
Am J Case Rep. 2020; 21:e923454.
PMID: 32649651
PMC: 7377528.
DOI: 10.12659/AJCR.923454.
A long history of dense deposit disease.
Cunningham A, Kotagiri A
BMC Ophthalmol. 2018; 18(Suppl 1):228.
PMID: 30255792
PMC: 6157191.
DOI: 10.1186/s12886-018-0853-8.
Retinal Basal Laminar Deposits in Complement fH/fP Mouse Model of Dense Deposit Disease.
Song D, Mohammed I, Bhuyan R, Miwa T, Williams A, Gullipalli D
Invest Ophthalmol Vis Sci. 2018; 59(8):3405-3415.
PMID: 30025090
PMC: 6040236.
DOI: 10.1167/iovs.18-24133.
Fundus changes in type III membranoproliferative glomerulonephritis: a case report.
Takei M, Obana A, Inomata T, Tanaka T, Shiang T, Bae Y
BMC Ophthalmol. 2018; 18(1):72.
PMID: 29510686
PMC: 5840715.
DOI: 10.1186/s12886-018-0738-x.
Retinal findings in membranoproliferative glomerulonephritis.
Mansour A, Lima L, Fernando Arevalo J, Amaro M, Lozano V, Bou Ghannam A
Am J Ophthalmol Case Rep. 2017; 7:83-90.
PMID: 29260086
PMC: 5722170.
DOI: 10.1016/j.ajoc.2017.06.011.
Benign Yellow Dot Maculopathy: A New Macular Phenotype.
Dev Borman A, Rachitskaya A, Suzani M, Sisk R, Ahmed Z, Holder G
Ophthalmology. 2017; 124(7):1004-1013.
PMID: 28366503
PMC: 5503697.
DOI: 10.1016/j.ophtha.2017.02.026.
Multimodal imaging of membranoproliferative glomerulonephritis type II.
Cebeci Z, Bayraktar S, Oray M, Kir N
Saudi J Ophthalmol. 2016; 30(4):260-263.
PMID: 28003788
PMC: 5161817.
DOI: 10.1016/j.sjopt.2016.11.005.
Posterior segment findings in a patient with immunotactoid glomerulonephritis.
Gupta A, Prabhu R, Patel A, Sivaraj R
GMS Ophthalmol Cases. 2016; 5:Doc01.
PMID: 27625945
PMC: 5015626.
DOI: 10.3205/oc000023.
Reclassification of membranoproliferative glomerulonephritis: Identification of a new GN: C3GN.
Salvadori M, Rosso G
World J Nephrol. 2016; 5(4):308-20.
PMID: 27458560
PMC: 4936338.
DOI: 10.5527/wjn.v5.i4.308.
Overview of C3 Glomerulopathy.
Raj V, Gordillo R, Chand D
Front Pediatr. 2016; 4:45.
PMID: 27200326
PMC: 4858534.
DOI: 10.3389/fped.2016.00045.